Background: Current therapies for lower urinary tract symptoms (LUTS) due to bladder-neck dyssynergia (BND) have many limitations. Objective: To determine efficacy and safety of OnabotulinumtoxinA (BoNT-A) injection therapy in medically-refractory patients with LUTS due to BND. Design, Setting, and Participants: Prospective single-armed cohort study. Therty-five consecutive ambulatory males, younger than 50 yr and diagnosed with BND refractory to medical therapy, with IPSS>15, Qmax<15 ml/s and total prostate volume <30 cm3, were screened from January 2010 and December 2011. Patients were assessed at baseline, two, six, nine and 12 mo postprocedure and until duration of clinical response. Intervention: Transurethral bladder-neck injectio...
P>Objective: To assess the safety and efficacy of botulinum toxin-A (botn-A) in the management of...
Botulinum neurotoxin (BoNT) is used to treat a variety of ailments, and its therapeutic application ...
Background: Lower Urinary Tract Symptoms (LUTS) in men are a common clinical problem in urology and ...
To determine efficacy and safety of OnabotulinumtoxinA (BoNT-A) injection therapy in medically refra...
Background/PurposeLower urinary tract symptoms (LUTS) in men with small benign prostatic hyper-plasi...
Lower urinary tract symptoms (LUTS) in men with small benign prostatic hyper-plasia (BPH) might not ...
OnabotulinumtoxinA (BoNT-A) was first used to treat neurogenic lower urinary tract dysfunction (LUTD...
AbstractDetrusor sphincter dyssynergia (DSD) and neurogenic detrusor overactivity (NDO) are common c...
Study Type--Therapy (prospective cohort) Level of Evidence 3a. What's known on the subject? and What...
Objective: Onabotulinumtoxin-A has been approved for wet overactive bladder refractory to anticholin...
Introduction: Our study aims to examine the treatment outcomes of patients with non-neurogenic detru...
Although intravesical injection of onabotulinumtoxinA (BoNT-A) has been proved promising in treating...
Botulinum toxin A (BoNT-A) is effective in reducing bladder hypersensitivity and increasing capacity...
Objective: We evaluated the efficacy and tolerability of botulinum A toxin (BTX-A) intravesical inje...
Context: Botulinum toxin A (BoNTA) has received regulatory approval for use in neurogenic detrusor o...
P>Objective: To assess the safety and efficacy of botulinum toxin-A (botn-A) in the management of...
Botulinum neurotoxin (BoNT) is used to treat a variety of ailments, and its therapeutic application ...
Background: Lower Urinary Tract Symptoms (LUTS) in men are a common clinical problem in urology and ...
To determine efficacy and safety of OnabotulinumtoxinA (BoNT-A) injection therapy in medically refra...
Background/PurposeLower urinary tract symptoms (LUTS) in men with small benign prostatic hyper-plasi...
Lower urinary tract symptoms (LUTS) in men with small benign prostatic hyper-plasia (BPH) might not ...
OnabotulinumtoxinA (BoNT-A) was first used to treat neurogenic lower urinary tract dysfunction (LUTD...
AbstractDetrusor sphincter dyssynergia (DSD) and neurogenic detrusor overactivity (NDO) are common c...
Study Type--Therapy (prospective cohort) Level of Evidence 3a. What's known on the subject? and What...
Objective: Onabotulinumtoxin-A has been approved for wet overactive bladder refractory to anticholin...
Introduction: Our study aims to examine the treatment outcomes of patients with non-neurogenic detru...
Although intravesical injection of onabotulinumtoxinA (BoNT-A) has been proved promising in treating...
Botulinum toxin A (BoNT-A) is effective in reducing bladder hypersensitivity and increasing capacity...
Objective: We evaluated the efficacy and tolerability of botulinum A toxin (BTX-A) intravesical inje...
Context: Botulinum toxin A (BoNTA) has received regulatory approval for use in neurogenic detrusor o...
P>Objective: To assess the safety and efficacy of botulinum toxin-A (botn-A) in the management of...
Botulinum neurotoxin (BoNT) is used to treat a variety of ailments, and its therapeutic application ...
Background: Lower Urinary Tract Symptoms (LUTS) in men are a common clinical problem in urology and ...